EWEdwards Lifesciences Corp

NYSE edwards.com


$ 88.02 $ -0.60 (-0.68 %)    

Thursday, 25-Apr-2024 15:59:53 EDT
QQQ $ 430.17 $ -2.06 (-0.48 %)
DIA $ 380.88 $ -3.52 (-0.92 %)
SPY $ 507.81 $ -1.92 (-0.38 %)
TLT $ 87.78 $ -0.62 (-0.7 %)
GLD $ 215.92 $ 1.28 (0.6 %)
$ 88.01
$ 87.64
$ 0.00 x 0
$ 0.00 x 0
$ 86.68 - $ 88.72
$ 60.57 - $ 96.12
4,295,297
na
53.63B
$ 1.17
$ 38.24
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-12-2024 12-31-2023 10-K
2 10-27-2023 09-30-2023 10-Q
3 07-28-2023 06-30-2023 10-Q
4 04-28-2023 03-31-2023 10-Q
5 02-13-2023 12-31-2022 10-K
6 10-28-2022 09-30-2022 10-Q
7 07-29-2022 06-30-2022 10-Q
8 04-28-2022 03-31-2022 10-Q
9 02-14-2022 12-31-2021 10-K
10 10-29-2021 09-30-2021 10-Q
11 07-30-2021 06-30-2021 10-Q
12 04-28-2021 03-31-2021 10-Q
13 02-12-2021 12-31-2020 10-K
14 10-26-2020 09-30-2020 10-Q
15 07-27-2020 06-30-2020 10-Q
16 04-28-2020 03-31-2020 10-Q
17 02-14-2020 12-31-2019 10-K
18 10-25-2019 09-30-2019 10-Q
19 07-26-2019 06-30-2019 10-Q
20 04-26-2019 03-31-2019 10-Q
21 02-15-2019 12-31-2018 10-K
22 10-26-2018 09-30-2018 10-Q
23 07-27-2018 06-30-2018 10-Q
24 04-27-2018 03-31-2018 10-Q
25 02-16-2018 12-31-2017 10-K
26 10-27-2017 09-30-2017 10-Q
27 07-28-2017 06-30-2017 10-Q
28 04-28-2017 03-31-2017 10-Q
29 02-17-2017 12-31-2016 10-K
30 10-28-2016 09-30-2016 10-Q
31 07-29-2016 06-30-2016 10-Q
32 04-29-2016 03-31-2016 10-Q
33 02-19-2016 12-31-2015 10-K
34 10-29-2015 09-30-2015 10-Q
35 07-29-2015 06-30-2015 10-Q
36 04-29-2015 03-31-2015 10-Q
37 02-20-2015 12-31-2014 10-K
38 10-31-2014 09-30-2014 10-Q
39 08-04-2014 06-30-2014 10-Q
40 05-02-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 edwards-lifesciences-q1-2024-adj-eps-066-beats-064-estimate-sales-1598b-beat-1569b-estimate

Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.6...

 rbc-capital-maintains-outperform-on-edwards-lifesciences-raises-price-target-to-101

RBC Capital analyst Shagun Singh maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from...

 mizuho-maintains-buy-on-edwards-lifesciences-raises-price-target-to-105

Mizuho analyst Anthony Petrone maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $95 to $...

 evercore-isi-group-maintains-in-line-on-edwards-lifesciences-raises-price-target-to-92

Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a In-Line and raises the price target f...

 citigroup-maintains-neutral-on-edwards-lifesciences-raises-price-target-to-98

Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences (NYSE:EW) with a Neutral and raises the price target from $9...

 otr-global-upgrades-edwards-lifesciences-to-positive

OTR Global upgrades Edwards Lifesciences (NYSE:EW) from Mixed to Positive.

 morgan-stanley-maintains-overweight-on-edwards-lifesciences-raises-price-target-to-103

Morgan Stanley analyst Patrick Wood maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target f...

 oppenheimer-maintains-outperform-on-edwards-lifesciences-raises-price-target-to-100

Oppenheimer analyst Suraj Kalia maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from ...

 b-of-a-securities-upgrades-edwards-lifesciences-to-buy

B of A Securities analyst Travis Steed upgrades Edwards Lifesciences (NYSE:EW) from Neutral to Buy.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION